Occurrence of Circulating Antibodies against the Hemagglutinins of Influenza Viruses in the 2022/2023 Epidemic Season in Poland
Viruses · 2024
DOI: 10.3390/v16071105 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Katarzyna Kondratiuk und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Influenza Viruses and Respiratory Viruses, Department of Virology, National Institute of Public Health NIH-National Research Institute,…. Hauptthemen laut MEDLINE: Influenza, Human, Antibodies, Viral, Hemagglutinin Glycoproteins, Influenza Virus, Influenza A Virus, H3N2 Subtype. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health (Poland), Minister of Health.
Abstract (Originalsprache)
The aim of this study was to determine the level of anti-hemagglutinin antibodies in blood sera collected from patients during the 2022/2023 epidemic season in Poland. A total of 700 sera samples from patients across the country were tested. The samples were divided into seven groups according to the age of the patients, with 100 samples from each age group. The hemagglutination inhibition test (OZHA) was used to determine the level of anti-hemagglutinin antibodies. The test results have confirmed the presence of anti-hemagglutinin antibodies for antigens A/Victoria/2570/2019 (H1N1)pdm09, A/Darwin/9/2021 (H3N2), B/Austria/1359417/2021 (B/Yamagata lineage) and B/ Phuket/3073/2013 (B/Victoria lineage) present in the influenza vaccine recommended by the World Health Organization (WHO) for the 2022/2023 epidemic season. The highest geometric mean antibody titres (GMT) and protection rate values (%) were recorded for hemagglutinin A/H3N2. In Poland, in the 2022/2023 epidemic season, the percentage of the population vaccinated against influenza was 5.7%. Therefore, the test results can be interpreted as the response of the immune system in patients who have been previously infected with an influenza virus.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Influenza Viruses and Respiratory Viruses, Department of Virology, National Institute of Public Health NIH-National Research Institute, 00-791 Warsaw, Poland.
- Department of Population Health Monitoring and Analysis, National Institute of Public Health NIH-National Research Institute, 00-791 Warsaw, Poland.
ORCID-Profile: Katarzyna Kondratiuk, Karol Szymański, Emilia Czajkowska, Bartosz Mańkowski
Förderung
- Ministry of Health (Poland)
- Minister of Health
Zitieren
APA
Kondratiuk, K., Poznańska, A., Szymański, K., Czajkowska, E., Mańkowski, B., & Brydak, L. B. (2024). Occurrence of Circulating Antibodies against the Hemagglutinins of Influenza Viruses in the 2022/2023 Epidemic Season in Poland. Viruses. https://doi.org/10.3390/v16071105
Vancouver
Kondratiuk K, Poznańska A, Szymański K, Czajkowska E, Mańkowski B, Brydak LB. Occurrence of Circulating Antibodies against the Hemagglutinins of Influenza Viruses in the 2022/2023 Epidemic Season in Poland. Viruses. 2024. doi:10.3390/v16071105
BibTeX
@article{Kondratiuk2024,
author = {Kondratiuk, Katarzyna and Poznańska, Anna and Szymański, Karol and Czajkowska, Emilia and Mańkowski, Bartosz and Brydak, Lidia B},
title = {Occurrence of Circulating Antibodies against the Hemagglutinins of Influenza Viruses in the 2022/2023 Epidemic Season in Poland},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16071105}
}
EUVIMED